World

UK records another 44,917 new coronavirus cases

Nov 23, 2021

London (UK), November 23: Britain registered 44,917 new COVID-19 infections, bringing the total number of coronavirus cases in the country to 9,889,926, according to official figures released Monday.
The country also reported a further 45 coronavirus-related deaths. The total number of coronavirus-related deaths in Britain now stands at 143,972, with 8,024 COVID-19 patients still in hospital.
The latest data came as British Prime Minister Boris Johnson said the COVID situation in Europe is a concern and "you've got to be humble in the face of nature".
Speaking to reporters after his speech at the Confederation of British Industry (CBI) annual conference, he noted there is "nothing in the data saying we need to move to Plan B" in Britain.
"The best single thing you can all do is get your booster. When you are called forward to get it, please do so," Johnson said.
Plan B involves advice to work at home and requirements to wear masks in certain scenarios.
More than 88 percent of people aged 12 and over in Britain have had their first dose of vaccine and more than 80 percent have received both doses, according to the latest figures. More than 26 percent have received booster jabs, or the third dose of a coronavirus vaccine.
To bring life back to normal, countries such as Britain, China, Germany, Russia and the United States have been racing against time to roll out coronavirus vaccines.
Source: Xinhua

More news

Nysh.in Introduces BluHeat Pain Relief Patches: Your Solution to Back Pain Woes!

Mumbai (Maharashtra) [India], April 19: Nysh.in, a trusted and leading provider of effective pain relief innovations, proudly announces the launch of its latest product - BluHeat Pain Relief Patches for back pain. Designed to address the needs of working professionals and home makers alike, who often endure back pain due to long hours of sitting or standing with poor posture, BluHeat Pain Relief Patches offer a natural, chemical-free solution that is trusted and certified for its efficacy.

Apr 19, 2024